Recent advances in deciphering oligodendrocyte heterogeneity with single-cell transcriptomics

Lukas Valihrach; Zuzana Matusova; Daniel Zucha; Ruslan Klassen; Sarka Benesova; Pavel Abaffy; Mikael Kubista; Miroslava Anderova

doi:10.3389/fncel.2022.1025012

Recent advances in deciphering oligodendrocyte heterogeneity with single-cell transcriptomics

Front Cell Neurosci. 2022 Oct 13:16:1025012. doi: 10.3389/fncel.2022.1025012. eCollection 2022.

Authors

Lukas Valihrach^{1

2}, Zuzana Matusova^{1

3}, Daniel Zucha^{1

4}, Ruslan Klassen^{1

5}, Sarka Benesova^{1

4}, Pavel Abaffy¹, Mikael Kubista^{1

6}, Miroslava Anderova²

Affiliations

¹ Laboratory of Gene Expression, Institute of Biotechnology of the Czech Academy of Sciences, Vestec, Czechia.
² Department of Cellular Neurophysiology, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czechia.
³ Faculty of Science, Charles University, Prague, Czechia.
⁴ Department of Informatics and Chemistry, Faculty of Chemical Technology, University of Chemistry and Technology, Prague, Czechia.
⁵ Department of Biochemistry and Microbiology, Faculty of Food and Biochemical Technology, University of Chemistry and Technology, Prague, Czechia.
⁶ TATAA Biocenter AB, Gothenburg, Sweden.

Abstract

Oligodendrocytes (OL) have been for decades considered a passive, homogenous population of cells that provide support to neurons, and show a limited response to pathological stimuli. This view has been dramatically changed by the introduction of powerful transcriptomic methods that have uncovered a broad spectrum of OL populations that co-exist within the healthy central nervous system (CNS) and also across a variety of diseases. Specifically, single-cell and single-nucleus RNA-sequencing (scRNA-seq, snRNA-seq) have been used to reveal OL variations in maturation, myelination and immune status. The newly discovered immunomodulatory role suggests that OL may serve as targets for future therapies. In this review, we summarize the current understanding of OL heterogeneity in mammalian CNS as revealed by scRNA-seq and snRNA-seq. We provide a list of key studies that identify consensus marker genes defining the currently known OL populations. This resource can be used to standardize analysis of OL related datasets and improve their interpretation, ultimately leading to a better understanding of OL functions in health and disease.

Keywords: heterogeneity; marker genes; oligodendrocyte; populations; scRNA-seq; snRNA-seq.

Publication types

Review